covid
Buscar en
GE - Portuguese Journal of Gastroenterology
Toda la web
Inicio GE - Portuguese Journal of Gastroenterology Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug...
Journal Information
Vol. 23. Issue 6.
Pages 335-336 (November - December 2016)
Share
Share
Download PDF
More article options
Vol. 23. Issue 6.
Pages 335-336 (November - December 2016)
Letter to the Editor
Open Access
Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?
Enteropatia Sprue-Like Associada com o Olmesartan: Uma Enteropatia Induzida por Fármaco Emergente e Sub-Diagnosticada?
Visits
4505
Luís Carvalho Lourenço
Corresponding author
luisclourenco@gmail.com

Corresponding author.
, Joana Carvalho e Branco, Liliana Santos, Alexandra Martins, Jorge Reis
Gastroenterology Department, Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal
Related content
GE Portuguese Journal of Gastroenterology. 2016;23:91-510.1016/j.jpge.2015.09.005
Marta Eusébio, Paulo Caldeira, Artur Gião Antunes, André Ramos, Francisco Velasco, Jesús Cadillá, Horácio Guerreiro
GE Portuguese Journal of Gastroenterology. 2016;23:96-10010.1016/j.jpge.2015.10.007
Bruno Moreira da Silva, Sofia Jardim Neves, Arantza Germade Martínez, Karina de Jesús Geneux, Jesús Lomas García, Sergio Maestro Antolín, Antonio Pérez Millán
GE Portuguese Journal of Gastroenterology. 2016;23:101-510.1016/j.jpge.2015.12.003
Liliana Carneiro, Albina Moreira, Adelina Pereira, Carina Andrade, José Soares, Artur Silva
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table 1. Clinical features of two cases of sprue-like enteropathy associated with olmesartan. F, Female; hypoK, hipokalemia; hypoAlb, hypoalbuminemia; hypoMg, hypomagnesemia.
Full Text
Dear Editors,

We read with great interest the case reports by da Silva et al.1, Carneiro et al.2 and Eusébio et al.3 published in the late issue of GE Portuguese Journal of Gastroenterology.

We would like to emphasize the clinical relevance of this topic regarding its, until recently, unrecognized features and share our small case-series experience (Table 1).

Table 1.

Clinical features of two cases of sprue-like enteropathy associated with olmesartan. F, Female; hypoK, hipokalemia; hypoAlb, hypoalbuminemia; hypoMg, hypomagnesemia.

Sex  Age  Time of diagnosis  Clinical presentation  Duration of symptoms  Laboratorial findings  Response to eviction of olmesartan  Time of follow-up endoscopy/histology  Resolution of histological changes 
72  2014  Chronic diarrhea; abdominal discomfort  6 months  Normocytic anemia; hypoK; hypoAlb  Clinical remission  3 months  Yes 
52  2015  Chronic diarrhea  4 months  Electrolyte abnormalities (severe hypoK and hypoMg)  Clinical remission  6 months  Yes 

Curiously, in both cases symptoms developed long (fourteen and ten months, respectively) after starting therapy. This has rarely been addressed and may difficult the diagnosis.

The primary care physicians were informed and advised to switch class of medication in these cases. There were no recurrences of symptoms during follow-up.

References
[1]
B.M. da Silva, S.J. Neves, A.G. Martínez, K. de Jesus Geneux, J.L. García, S.M. Antolín, et al.
Enteropathy associated with olmesartan.
GE Port J Gastroenterol, 23 (2016), pp. 96-100
[2]
L. Carneiro, A. Moreira, A. Pereira, A. Andrade, J. Soares, A. Silva, et al.
Olmesartan-induced sprue like enteropathy.
GE Port J Gastroenterol, 23 (2016), pp. 101-105
[3]
M. Eusébio, P. Caldeira, A. Gião Antunes, A. Ramos, F. Velasco, J. Cadillá, et al.
Olmesartan-induced enteropathy – an unusual cause of villous atrophy.
GE Port J Gastroenterol, 23 (2016), pp. 91-95
Copyright © 2016. Sociedade Portuguesa de Gastrenterologia
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos